By focusing on HCC models, we now established that such antagonism regulates CAF responses to TGFβ signaling, at least in part via a gene regulatory mechanism whereby LXRα limits the TGFβ inducibility of target genes, such as αSMA/ACTA2 (Figs. 1–5). The gene discussed is NR1H3; the disease is hepatocellular carcinoma.